WLWT: Pandemic creates education crisis
Education expert explains far-reaching impact on schools, economy
Mary Boat, the director of the University of Cincinnati's School of Education, was featured on WLWT-TV, Channel 5, discussing the disruption of learning during the pandemic and the effect remote classes will have on school children for years to come.
"We talk a lot about economic recovery after COVID; we need to be talking about educational recovery," said Boat, explaining how the pandemic has expanded an already existing achievement gap between diverse groups of learners.
The UC School of Education is part of the College of Education, Criminal Justice and Human Services.
Boat's primary research focus is on young children with or at risk for disabilities. She has conducted research and published in the areas of social competence in preschool age children with disabilities, program development in teacher education, effective instruction in preschool settings/Head Start and assessment in early childhood.
Watch the entire WLWT interview.
Featured photo at top of books and a laptop courtesy of Adobe.
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Related Stories
UC biologist talks about 'pearmageddon'
March 16, 2026
WLWT talks to UC biologist and Department Head Theresa Culley about invasive, nonnative Callery pear trees that are spreading across Ohio forests after they were introduced by landscapers more than 50 years ago.
Local media highlight completion of Blood Cancer Healing Center fourth and fifth floors
March 16, 2026
Local media including WLWT and the Cincinnati Business Courier highlighted the opening of research laboratories and the UC Osher Wellness Suite and Learning Kitchen at the University of Cincinnati Cancer Center’s Blood Cancer Healing Center.
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.